These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 19302064)

  • 1. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
    Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
    Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
    Sugden MC; Priestman DA; Orfali KA; Holness MJ
    Horm Metab Res; 1999 May; 31(5):300-6. PubMed ID: 10422724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA.
    Holness MJ; Priestman DA; Sugden MC
    J Mol Cell Cardiol; 1998 Jul; 30(7):1381-90. PubMed ID: 9710806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
    Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
    J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
    Aires CC; Ijlst L; Stet F; Prip-Buus C; de Almeida IT; Duran M; Wanders RJ; Silva MF
    Biochem Pharmacol; 2010 Mar; 79(5):792-9. PubMed ID: 19854160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
    Velasco G; Geelen MJ; Guzmán M
    Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of proglycosyn (LY177507) on fatty acid metabolism in rat hepatocytes.
    Guzmán M; Geelen MJ; Harris RA
    Arch Biochem Biophys; 1993 Aug; 305(1):141-6. PubMed ID: 8102045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal control of fatty acid oxidation during the neonatal period.
    Pegorier JP; Prip-Buus C; Duee PH; Girard J
    Diabete Metab; 1992; 18(1 Pt 2):156-60. PubMed ID: 1563551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1.
    Giordano A; Calvani M; Petillo O; Grippo P; Tuccillo F; Melone MA; Bonelli P; Calarco A; Peluso G
    Cell Death Differ; 2005 Jun; 12(6):603-13. PubMed ID: 15846373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification.
    Bruce CR; Brolin C; Turner N; Cleasby ME; van der Leij FR; Cooney GJ; Kraegen EW
    Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1231-7. PubMed ID: 17179390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
    Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of N- and C-terminal domain intramolecular interactions in rat liver carnitine palmitoyltransferase 1 that determine its degree of malonyl-CoA sensitivity.
    Faye A; Borthwick K; Esnous C; Price NT; Gobin S; Jackson VN; Zammit VA; Girard J; Prip-Buus C
    Biochem J; 2005 Apr; 387(Pt 1):67-76. PubMed ID: 15498023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
    Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the sensitivity of carnitine palmitoyltransferase I to inhibition by malonyl-CoA is an important site of regulation of hepatic fatty acid oxidation in the fetal and newborn rabbit. Perinatal development and effects of pancreatic hormones in cultured rabbit hepatocytes.
    Prip-Buus C; Pegorier JP; Duee PH; Kohl C; Girard J
    Biochem J; 1990 Jul; 269(2):409-15. PubMed ID: 2167069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance.
    Sebastián D; Herrero L; Serra D; Asins G; Hegardt FG
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E677-86. PubMed ID: 17062841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
    Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
    Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid switch of hepatic fatty acid metabolism from oxidation to esterification during diurnal feeding of meal-fed rats correlates with changes in the properties of acetyl-CoA carboxylase, but not of carnitine palmitoyltransferase I.
    Moir AM; Zammit VA
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):241-6. PubMed ID: 8097087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle.
    Kim JY; Koves TR; Yu GS; Gulick T; Cortright RN; Dohm GL; Muoio DM
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1014-22. PubMed ID: 11934665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.